An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Fulgent Genetics, Inc. (NASDAQ: FLGT) will release its Q2 2022 financial results on August 4, 2022, after market close. Key executives, including Chairman Ming Hsieh and CFO Paul Kim, will host a conference call at 4:30 PM ET to discuss the results and answer investor questions. The call can be accessed via audio webcast on the company's website or by phone. Fulgent specializes in genetic testing for oncology, infectious and rare diseases, and reproductive health, offering a flexible test menu and high accuracy through its proprietary technology platform.
Positive
Strong focus on transforming healthcare in oncology, infectious diseases, and reproductive health.
Expansion of genetic testing capabilities through advanced technology and competitive pricing.
Negative
None.
TEMPLE CITY, Calif.--(BUSINESS WIRE)--
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced that it will release its second quarter 2022 financial results after the market closes on Thursday, August 4, 2022. The company’s Chairman and Chief Executive Officer Ming Hsieh, Chief Financial Officer Paul Kim, Chief Commercial Officer Brandon Perthuis, and Chief Medical Officer Dr. Larry Weiss will host a conference call for the investment community the same day at 4:30 PM ET (1:30 PM PT) to discuss the results and answer questions.
The call can be accessed through a live audio webcast in the Investors section of the company’s website, http://ir.fulgentgenetics.com, and through a live conference call by dialing (888) 221-3881 using the confirmation code 6448347. An audio replay will be available in the Investors section of the company’s website.
About Fulgent Genetics
Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. Fulgent Genetics’ proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy, and competitive turnaround times. Combining next generation sequencing, or NGS, with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. A cornerstone of the Company’s business is its ability to provide expansive options and flexibility for all clients’ unique testing needs through a comprehensive technology offering including cloud computing, pipeline services, record management, web portal services, clinical workflow, sequencing as a service and automated laboratory services.
Investor Relations Contact:
The Blueshirt Group Nicole Borsje, 415-217-2633
nicole@blueshirtgroup.com
Source: Fulgent Genetics, Inc.
FAQ
When will Fulgent Genetics release its Q2 2022 financial results?
Fulgent Genetics will release its Q2 2022 financial results on August 4, 2022, after market close.
What time is the Fulgent Genetics conference call for Q2 2022 results?
The conference call will take place at 4:30 PM ET on August 4, 2022.
How can I access the Fulgent Genetics conference call?
You can access the conference call via audio webcast on Fulgent's website or by dialing (888) 221-3881 with the confirmation code 6448347.
What is Fulgent Genetics known for?
Fulgent Genetics is known for its technology-based genetic testing services, focusing on oncology, infectious diseases, rare diseases, and reproductive health.
What technology does Fulgent Genetics use for genetic testing?
Fulgent Genetics uses next generation sequencing (NGS) combined with its proprietary technology platform for genetic testing.
